Irritable Bowel Syndrome
Irritable Bowel Syndrome (IBS) is a common gastrointestinal disorder that affects how your intestines function, leading to symptoms like abdominal pain, bloating, and changes in bowel habits such as diarrhea or constipation.
We are investigating how fecal microbiota transplantation may affect enzyme activities in the body. This study aims to understand its potential benefits for patients with certain health conditions.
Health conditions and diseases that the clinical trial is designed to study and treat.
Irritable Bowel Syndrome (IBS) is a common gastrointestinal disorder that affects how your intestines function, leading to symptoms like abdominal pain, bloating, and changes in bowel habits such as diarrhea or constipation.
Clostridioides difficile infection (CDI) is a bacterial infection that can cause severe diarrhea and colitis, often occurring after antibiotic use, leading to symptoms like watery stools, fever, and abdominal pain.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.